Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Two nitrogen mustard derivatives, as well as preparation method and application therefore in tumor treatment

A technology for tumor treatment and derivatives, applied in the direction of anti-tumor drugs, drug combinations, pharmaceutical formulations, etc., can solve the problems of not fully tapping the potential of anti-tumor drugs, and achieve good anti-cancer activity, easy preparation, and low toxicity Effect

Inactive Publication Date: 2013-12-18
BEIJING NORMAL UNIVERSITY
View PDF3 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there are only a few reports on the research of nitrogen mustard compounds with quinazoline derivatives as anti-tumor drugs, and the potential of these compounds as anti-tumor drugs has not been fully tapped.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Two nitrogen mustard derivatives, as well as preparation method and application therefore in tumor treatment
  • Two nitrogen mustard derivatives, as well as preparation method and application therefore in tumor treatment
  • Two nitrogen mustard derivatives, as well as preparation method and application therefore in tumor treatment

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0069] Compounds of the formula A in which the substituents R1=hydrogen, R2=nitrogen mustard are prepared according to the following steps.

[0070] 1.1 Synthesis of N, N-bis(2-hydroxyethyl)-3-nitroaniline

[0071] Take 5.52 g (0.04 mol) of 3-nitroaniline, add it to 80 mL of 25% acetic acid aqueous solution, and add 10 mL of ethylene oxide dropwise under ice cooling. Warm up to room temperature, stir for 72 hours, filter with suction, wash the filter cake with water, and dry to obtain 8.02 g of a yellow-orange solid, with a yield of 88%. mp94-96℃, 1 H NMR (400MHz, CDCl 3 )δ7.53 (d, J=8.0Hz, 1H, ArH), 7.48 (s, 1H, ArH), 7.33 (t, J=8.2Hz, 1H, ArH), 6.97 (dd, J=8.4, 2.2Hz , 1H, ArH), 3.89 (t, J=4.8Hz, 4H, -NCH 2 CH2-), 3.65(t, J=4.8Hz, 4H, -CH 2 CH 2 OH). 13 C NMR (100MHz, CDCl 3 )δ149.43, 148.63, 129.84, 118.10, 111.34, 106.48, 60.35, 55.06.MS (ESI + ) m / z: 227.3 (M+H + ).IR(KBr pellet, cm -1 ): 3265, 3173, 2959, 2863, 1618, 1565, 1525, 1486, 1341, 1290, 1040.

[007...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses novel nitrogen mustard derivatives. The nitrogen mustard derivatives are characterized in that a nitrogen mustard alkylation group is at one end, a 6,7-substituted quinazoline structure is at the other end, the substituent R1 is located at the 4th position of the quinazoline main body and is 2-nitrogen mustard group or 3-nitrogen mustard group, morpholinepropoxy and methoxy are located at the 6th position and the 7th position of the quinazoline main body, and the structural formula is shown in formula A. Experiments prove that the compounds can inhibit the cell cycle at the G2 / M period and are di-functional alkylation agents. The in-vivo anti-tumor activity experiments prove that the compounds are quite good in activity. In addition, the compounds have the superiority to other nitrogen mustard medicines, namely, the compounds are quite low in toxicity. Simultaneously, the compounds are easy to synthesize, and quite high in total yield. All the above advantages prove that the compounds have great potential to function as medicines for treating tumors.

Description

Technical field: [0001] The invention relates to two novel nitrogen mustard derivatives, their preparation method and their application as tumor treatment drugs. Background technique: [0002] Tumor is a disease that seriously threatens human health. Over the years, scientists from various countries have made unremitting efforts to find out more suitable tumor chemotherapy drugs for tumor treatment. [0003] Nitrogen mustards are the earliest anti-tumor alkylating agents used clinically. Since their inception, the development of new nitrogen mustards has been going on for a long time. In the development process of nitrogen mustard drugs, how to introduce new drug carriers to reduce drug toxicity and increase tumor selectivity, thereby improving the therapeutic index, is the common goal of scientists from all over the world. At present, research based on this idea is mainly focused on the following three directions: introducing sugars and their derivatives into drug molecul...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D239/94A61P35/00
CPCA61K31/5377A61P35/00C07D239/94
Inventor 齐传民李石磊王潇贺勇陈玉蓉赵明霞宁红玉
Owner BEIJING NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products